Your browser doesn't support javascript.
loading
Early intestinal microbial features are associated with CD4 T-cell recovery after allogeneic hematopoietic transplant.
Miltiadous, Oriana; Waters, Nicholas R; Andrlová, Hana; Dai, Anqi; Nguyen, Chi L; Burgos da Silva, Marina; Lindner, Sarah; Slingerland, John; Giardina, Paul; Clurman, Annelie; Armijo, Gabriel K; Gomes, Antonio L C; Lakkaraja, Madhavi; Maslak, Peter; Scordo, Michael; Shouval, Roni; Staffas, Anna; O'Reilly, Richard; Taur, Ying; Prockop, Susan; Boelens, Jaap Jan; Giralt, Sergio; Perales, Miguel-Angel; Devlin, Sean M; Peled, Jonathan U; Markey, Kate A; van den Brink, Marcel R M.
Afiliação
  • Miltiadous O; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Waters NR; Department of Immunology, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center (MSKCC), New York, NY.
  • Andrlová H; Department of Immunology, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center (MSKCC), New York, NY.
  • Dai A; Department of Immunology, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center (MSKCC), New York, NY.
  • Nguyen CL; Department of Immunology, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center (MSKCC), New York, NY.
  • Burgos da Silva M; Department of Immunology, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center (MSKCC), New York, NY.
  • Lindner S; Department of Immunology, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center (MSKCC), New York, NY.
  • Slingerland J; Department of Immunology, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center (MSKCC), New York, NY.
  • Giardina P; Department of Immunology, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center (MSKCC), New York, NY.
  • Clurman A; Department of Immunology, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center (MSKCC), New York, NY.
  • Armijo GK; Department of Immunology, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center (MSKCC), New York, NY.
  • Gomes ALC; Department of Immunology, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center (MSKCC), New York, NY.
  • Lakkaraja M; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Maslak P; Department of Pediatrics, Weill Cornell Medicine, New York, NY.
  • Scordo M; Immunology Laboratory Service, Department of Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Shouval R; Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Staffas A; Department of Medicine, Weill Cornell Medical College, New York, NY.
  • O'Reilly R; Department of Medicine, Weill Cornell Medical College, New York, NY.
  • Taur Y; Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Prockop S; Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Boelens JJ; Sahlgrenska Center for Cancer Research, Department of Microbiology and Immunology, Institute of Biomedicine, University of Gothenburg, Sweden.
  • Giralt S; Clinical Genetics and Genomics, Sahlgrenska University Hospital, Gothenburg, Sweden.
  • Perales MA; Stem Cell Transplant and Cellular Therapy Service, Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Devlin SM; Department of Medicine, Weill Cornell Medical College, New York, NY.
  • Peled JU; Infectious Disease Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Markey KA; Department of Pediatrics, Weill Cornell Medicine, New York, NY.
  • van den Brink MRM; Stem Cell Transplant and Cellular Therapy Service, Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY.
Blood ; 139(18): 2758-2769, 2022 05 05.
Article em En | MEDLINE | ID: mdl-35061893
Low intestinal microbial diversity is associated with poor outcomes after allogeneic hematopoietic cell transplantation (HCT). Using 16S rRNA sequencing of 2067 stool samples and flow cytometry data from 2370 peripheral blood samples drawn from 894 patients who underwent allogeneic HCT, we have linked features of the early post-HCT microbiome with subsequent immune cell recovery. We examined lymphocyte recovery and microbiota features in recipients of both unmodified and CD34-selected allografts. We observed that fecal microbial diversity was an independent predictor of CD4 T-cell count 3 months after HCT in recipients of a CD34-selected allograft, who are dependent on de novo lymphopoiesis for their immune recovery. In multivariate models using clinical factors and microbiota features, we consistently observed that increased fecal relative abundance of genus Staphylococcus during the early posttransplant period was associated with worse CD4 T-cell recovery. Our observations suggest that the intestinal bacteria, or the factors they produce, can affect early lymphopoiesis and the homeostasis of allograft-derived T cells after transplantation.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Doença Enxerto-Hospedeiro Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Blood Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Doença Enxerto-Hospedeiro Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Blood Ano de publicação: 2022 Tipo de documento: Article